[HTML][HTML] Multicenter case–control study of COVID-19–associated mucormycosis outbreak, India

V Muthu, R Agarwal, SM Rudramurthy… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
In support of improving patient care, this activity has been planned and implemented by
Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with …

Coronavirus disease 2019–associated mucormycosis: risk factors and mechanisms of disease

S Narayanan, JV Chua… - Clinical Infectious Diseases, 2022 - academic.oup.com
The severe surge of coronavirus disease 2019 (COVID-19) cases on the Indian
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …

COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum

S Dubey, D Mukherjee, P Sarkar… - Diabetes & Metabolic …, 2021 - Elsevier
Aims: 1 Describe the epidemiology and determine risk factors for COVID-19 associated
mucormycosis. 2 Elaborate the clinical spectrum of Rhino-Orbital-Cerebral Mucormycosis …

COVID-19-associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: a retrospective multicenter observational cohort during the …

S Bretagne, K Sitbon, F Botterel, S Dellière… - Microbiology …, 2021 - Am Soc Microbiol
The aim of this study was to evaluate diagnostic means, host factors, delay of occurrence,
and outcome of patients with COVID-19 pneumonia and fungal coinfections in the intensive …

Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India

T Choksi, A Agrawal, P Date, D Rathod… - JAMA …, 2022 - jamanetwork.com
Importance An outbreak of COVID-19–associated rhino-orbitocerebral mucormycosis (CAM)
has occurred in many parts of the world. Although the clinical profile and risk factors for CAM …

[HTML][HTML] Outbreak of mucormycosis in coronavirus disease patients, Pune, India

S Joshi, R Telang, M Tambe, R Havaldar… - Emerging infectious …, 2022 - ncbi.nlm.nih.gov
We provide an overview of the epidemiology and clinical course of mucormycosis in the
coronavirus disease (COVID-19) pandemic era. We conducted a retrospective chart review …

Mucormycosis in the COVID-19 environment: a multifaceted complication

R Sharma, P Kumar, A Rauf, A Chaudhary… - Frontiers in cellular …, 2022 - frontiersin.org
The second wave of coronavirus disease 2019 (COVID-19) caused severe infections with
high mortality. An increase in the cases of COVID-19-associated mucormycosis (CAM) was …

Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality

A Budhraja, A Basu, A Gheware… - Disease Models & …, 2022 - journals.biologists.com
To elucidate the molecular mechanisms that manifest lung abnormalities during severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, we performed whole …

Cerebrovascular involvement in mucormycosis in COVID-19 pandemic

R Kulkarni, SS Pujari, D Gupta, P Ojha… - Journal of Stroke and …, 2022 - Elsevier
Background Many countries have seen an unprecedented rise of cases of coronavirus
disease 2019 (COVID-19) associated mucormycosis (CAM). Cerebrovascular involvement …

Retrobulbar injection of amphotericin B in patients with COVID-19 associated orbital mucormycosis: a systematic review

A Sharifi, Z Akbari, M Shafie'ei, N Nasiri… - Ophthalmic Plastic & …, 2022 - journals.lww.com
Purpose: Following COVID-19 infection a rising count of rhino-orbito-cerebral mucormycosis
is observed, requiring orbital exenteration, a disabling lifetime affecting surgery. One of the …